TrialBritish journal of cancer2004

A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours.

L Wall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.